** Shares of Australia's Control Bionics CBL.AX rise as much as 4.8% to A$0.044, its highest level since February 17
** The medical device manufacturer raises A$2.0 million ($1.27 million) via private placement at an issue price of A$0.045 per share
** Issue price represents a premium of 7.1% to stock's last closing
** Funds raised to help the company "focus on revenue growth in its core operations and the expansion into new high-potential markets" — CBL
** Stock has fallen 26.7% this year, as of 0118 GMT
($1 = 1.5778 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。